Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Bone Biologics CorpBBLG · Entity 8560 | affiliate of 10% owner/dir | January 02, 2020 | January 17, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Bone Biologics Corp
Report date January 02, 2020 · Filed January 17, 2020
Jointly reported with Hankey Don, HANKEY CAPITAL, LLC
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectBy Hankey Capital, LLC | 28,563,398 |
Reported balance
After 2020-01-02 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2020-01-02 · Purchase · Acquired 195,000 · Balance 28,563,398 F1: Consists of shares transferred from H&H Funding LLC ("H&H") to Hankey Capital LLC ("Hankey Capital"). Hankey Capital is owned by Hankey Investment Company LP ("HIC") of which the Don Hankey Trust (the "Trust") owns a 66.09% interest. HIC is owned by Knight Services Inc. of which the Trust is the sole owner. Don Hankey is the sole trustee of the Trust. Mr. Hankey is the sole manager of H&H. Mr. Hankey disclaims beneficial ownership in the shares held by Hankey Capital and H&H except to the extent of his pecuniary interest. F2: Mr. Hankey is the beneficial owner of 28,563,398 shares of the Company consisting of 4,062,870 shares owned by Hankey Capital, 23,404,255 Collateral Shares for which Hankey Capital has voting rights, 335,000 shares issuable to Hankey Capital upon conversion of debt, 361,640 shares owned by the Don Hankey Trust (the "Trust") of which Mr. Hankey is the Trustee, 79,240 shares held by H&H Funding LLC and 320,393 shares issuable upon exercise of warrants issued to Hankey Capital. |
Filing footnotes · ownership attribution and instrument terms
F1: Consists of shares transferred from H&H Funding LLC ("H&H") to Hankey Capital LLC ("Hankey Capital"). Hankey Capital is owned by Hankey Investment Company LP ("HIC") of which the Don Hankey Trust (the "Trust") owns a 66.09% interest. HIC is owned by Knight Services Inc. of which the Trust is the sole owner. Don Hankey is the sole trustee of the Trust. Mr. Hankey is the sole manager of H&H. Mr. Hankey disclaims beneficial ownership in the shares held by Hankey Capital and H&H except to the extent of his pecuniary interest.
F2: Mr. Hankey is the beneficial owner of 28,563,398 shares of the Company consisting of 4,062,870 shares owned by Hankey Capital, 23,404,255 Collateral Shares for which Hankey Capital has voting rights, 335,000 shares issuable to Hankey Capital upon conversion of debt, 361,640 shares owned by the Don Hankey Trust (the "Trust") of which Mr. Hankey is the Trustee, 79,240 shares held by H&H Funding LLC and 320,393 shares issuable upon exercise of warrants issued to Hankey Capital.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 02, 2020 Filed Jan 17, 2020 22:22 UTC | Bone Biologics Corp BBLG · Entity 8560 | PurchaseCommon Stock | 195,000 | $1.00 | $195,000.00 |
DisclosureSEC source: 0001493152-20-000773 · ownership.xml · nonDerivative · entry 1 Hankey Don · CIK 0001561288 · Director · Chairman of the Board · 10% owner HANKEY CAPITAL, LLC · CIK 0001675964 · 10% owner Don Hankey Trust · CIK 0001747743 · affiliate of 10% owner/dir Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Hankey Capital, LLC Disclosed balance after: 28,563,398 F1 · shares: Consists of shares transferred from H&H Funding LLC ("H&H") to Hankey Capital LLC ("Hankey Capital"). Hankey Capital is owned by Hankey Investment Company LP ("HIC") of which the Don Hankey Trust (the "Trust") owns a 66.09% interest. HIC is owned by Knight Services Inc. of which the Trust is the sole owner. Don Hankey is the sole trustee of the Trust. Mr. Hankey is the sole manager of H&H. Mr. Hankey disclaims beneficial ownership in the shares held by Hankey Capital and H&H except to the extent of his pecuniary interest. F2 · balance_after: Mr. Hankey is the beneficial owner of 28,563,398 shares of the Company consisting of 4,062,870 shares owned by Hankey Capital, 23,404,255 Collateral Shares for which Hankey Capital has voting rights, 335,000 shares issuable to Hankey Capital upon conversion of debt, 361,640 shares owned by the Don Hankey Trust (the "Trust") of which Mr. Hankey is the Trustee, 79,240 shares held by H&H Funding LLC and 320,393 shares issuable upon exercise of warrants issued to Hankey Capital. Read SEC document |
| August 06, 2019 Filed Aug 8, 2019 17:46 UTC | Bone Biologics Corp BBLG · Entity 8560 | PurchaseCommon Stock | 553,191 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-19-011866 · ownership.xml · nonDerivative · entry 1 Hankey Don · CIK 0001561288 · Director · Chairman of the Board · 10% owner HANKEY CAPITAL, LLC · CIK 0001675964 · 10% owner Don Hankey Trust · CIK 0001747743 · affiliate of 10% owner/dir Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Hankey Capital, LLC Disclosed balance after: 28,465,740 F1 · shares: Consists of shares held by Hankey Capital LLC ("Hankey Capital") as collateral for the repayment of convertible notes (the "Notes") issued to Hankey Capital (the "Collateral Shares"). Hankey Capital may not transfer, sell or otherwise dispose of any of the Collateral Shares, except during the existence of Event of Default under the Notes in connection with the exercise of its rights and remedies as a secured lender. Hankey Capital is owned by Hankey Investment Company LP ("HIC") of which the Don Hankey Trust (the "Trust") owns a 66.09% interest. HIC is owned by Knight Services Inc. of which the Trust is the sole owner. Don Hankey is the sole trustee of the Trust. Mr. Hankey disclaims beneficial ownership in the shares held by Hankey Capital except to the extent of his pecuniary interest. F2 · balance_after: Mr. Hankey is the beneficial owner of 28,465,740 shares of the Company consisting of 3,867,870 shares owned by Hankey Capital, 23,404,255 Collateral Shares for which Hankey Capital has voting rights, 361,640 shares owned by the Don Hankey Trust (the "Trust") of which Mr. Hankey is the Trustee, 274,240 shares held by H&H Funding LLC of which Mr. Hankey is the sole manager and 557,735 shares issuable upon exercise of warrants issued to Hankey Capital. Read SEC document |
| July 15, 2019 Filed Jul 17, 2019 18:05 UTC | Bone Biologics Corp BBLG · Entity 8560 | PurchaseCommon Stock | 85,106 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-19-010727 · ownership.xml · nonDerivative · entry 1 Hankey Don · CIK 0001561288 · Director · Chairman of the Board · 10% owner HANKEY CAPITAL, LLC · CIK 0001675964 · 10% owner Don Hankey Trust · CIK 0001747743 · affiliate of 10% owner/dir Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Hankey Capital, LLC Disclosed balance after: 27,912,549 F1 · shares: Consists of shares held by Hankey Capital LLC ("Hankey Capital") as collateral for the repayment of convertible notes (the "Notes") issued to Hankey Capital (the "Collateral Shares"). Hankey Capital may not transfer, sell or otherwise dispose of any of the Collateral Shares, except during the existence of Event of Default under the Notes in connection with the exercise of its rights and remedies as a secured lender. Hankey Capital is owned by Hankey Investment Company LP ("HIC") of which the Don Hankey Trust (the "Trust") owns a 66.09% interest. HIC is owned by Knight Services Inc. of which the Trust is the sole owner. Don Hankey is the sole trustee of the Trust. Mr. Hankey disclaims beneficial ownership in the shares held by Hankey Capital except to the extent of his pecuniary interest. F2 · balance_after: Mr. Hankey is the beneficial owner of 27,912,549 shares of the Company consisting of 3,867,870 shares owned by Hankey Capital, 22,851,064 Collateral Shares for which Hankey Capital has voting rights, 361,640 shares owned by the Don Hankey Trust (the "Trust") of which Mr. Hankey is the Trustee, 274,240 shares held by H&H Funding LLC of which Mr. Hankey is the sole manager and 557,735 shares issuable upon exercise of warrants issued to Hankey Capital. Read SEC document |
| June 20, 2019 Filed Jun 21, 2019 19:39 UTC | Bone Biologics Corp BBLG · Entity 8560 | PurchaseCommon Stock | 1,063,830 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-19-009561 · ownership.xml · nonDerivative · entry 1 Hankey Don · CIK 0001561288 · Director · Chairman of the Board · 10% owner HANKEY CAPITAL, LLC · CIK 0001675964 · 10% owner Don Hankey Trust · CIK 0001747743 · affiliate of 10% owner/dir Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Hankey Capital, LLC Disclosed balance after: Not disclosed F1 · shares: Consists of shares held by Hankey Capital LLC ("Hankey Capital") as collateral for the repayment of convertible notes (the "Notes") issued to Hankey Capital (the "Collateral Shares"). Hankey Capital may not transfer, sell or otherwise dispose of any of the Collateral Shares, except during the existence of Event of Default under the Notes in connection with the exercise of its rights and remedies as a secured lender. Hankey Capital is owned by Hankey Investment Company LP ("HIC") of which the Don Hankey Trust (the "Trust") owns a 66.09% interest. HIC is owned by Knight Services Inc. of which the Trust is the sole owner. Don Hankey is the sole trustee of the Trust. Mr. Hankey disclaims beneficial ownership in the shares held by Hankey Capital except to the extent of his pecuniary interest. F2 · valueOwnedAfter: Mr. Hankey is the beneficial owner of 27,827,443 shares of the Company consisting of 3,867,870 shares owned by Hankey Capital, 22,765,958 Collateral Shares for which Hankey Capital has voting rights, 361,640 shares owned by the Don Hankey Trust (the "Trust") of which Mr. Hankey is the Trustee, 274,240 shares held by H&H Funding LLC of which Mr. Hankey is the sole manager and 557,735 shares issuable upon exercise of warrants issued to Hankey Capital. Read SEC document |
| May 07, 2019 Filed May 24, 2019 18:07 UTC | Bone Biologics Corp BBLG · Entity 8560 | PurchaseCommon Stock | 1,063,830 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-19-008227 · ownership.xml · nonDerivative · entry 1 Hankey Don · CIK 0001561288 · Director · Chairman of the Board · 10% owner HANKEY CAPITAL, LLC · CIK 0001675964 · 10% owner Don Hankey Trust · CIK 0001747743 · affiliate of 10% owner/dir Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Hankey Capital, LLC Disclosed balance after: 26,763,613 F1 · shares: Consists of shares held by Hankey Capital LLC ("Hankey Capital") as collateral for the repayment of convertible notes (the "Notes") issued to Hankey Capital (the "Collateral Shares"). Hankey Capital may not transfer, sell or otherwise dispose of any of the Collateral Shares, except during the existence of Event of Default under the Notes in connection with the exercise of its rights and remedies as a secured lender. Hankey Capital is owned by Hankey Investment Company LP ("HIC") of which the Don Hankey Trust (the "Trust") owns a 66.09% interest. HIC is owned by Knight Services Inc. of which the Trust is the sole owner. Don Hankey is the sole trustee of the Trust. Mr. Hankey disclaims beneficial ownership in the shares held by Hankey Capital except to the extent of his pecuniary interest. F2 · balance_after: Mr. Hankey is the beneficial owner of 26,763,613 shares of the Company consisting of 3,867,870 shares owned by Hankey Capital, 21,702,128 Collateral Shares for which Hankey Capital has voting rights, 361,640 shares owned by the Don Hankey Trust (the "Trust") of which Mr. Hankey is the Trustee, 274,240 shares held by H&H Funding LLC of which Mr. Hankey is the sole manager and 557,735 shares issuable upon exercise of warrants issued to Hankey Capital. Read SEC document |
| March 25, 2019 Filed Mar 26, 2019 19:28 UTC | Bone Biologics Corp BBLG · Entity 8560 | PurchaseCommon Stock | 1,489,362 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-19-003931 · ownership.xml · nonDerivative · entry 2 Hankey Don · CIK 0001561288 · Director · Chairman of the Board · 10% owner HANKEY CAPITAL, LLC · CIK 0001675964 · 10% owner Don Hankey Trust · CIK 0001747743 · affiliate of 10% owner/dir Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Hankey Capital, LLC Disclosed balance after: 25,699,783 F1 · shares: Consists of shares held by Hankey Capital LLC ("Hankey Capital") as collateral for the repayment of convertible notes (the "Notes") issued to Hankey Capital (the "Collateral Shares"). Hankey Capital may not transfer, sell or otherwise dispose of any of the Collateral Shares, except during the existence of Event of Default under the Notes in connection with the exercise of its rights and remedies as a secured lender. Hankey Capital is owned by Hankey Investment Company LP ("HIC") of which the Don Hankey Trust (the "Trust") owns a 66.09% interest. HIC is owned by Knight Services Inc. of which the Trust is the sole owner. Don Hankey is the sole trustee of the Trust. Mr. Hankey disclaims beneficial ownership in the shares held by Hankey Capital except to the extent of his pecuniary interest. F2 · balance_after: Mr. Hankey is the beneficial owner of 25,699,783 shares of the Company consisting of 3,867,870 shares owned by Hankey Capital, 20,638,298 Collateral Shares for which Hankey Capital has voting rights, 361,640 shares owned by the Don Hankey Trust (the "Trust") of which Mr. Hankey is the Trustee, 274,240 shares held by H&H Funding LLC of which Mr. Hankey is the sole manager and 557,735 shares issuable upon exercise of warrants issued to Hankey Capital. Read SEC document |
| December 17, 2018 Filed Mar 26, 2019 19:28 UTC | Bone Biologics Corp BBLG · Entity 8560 | PurchaseCommon Stock | 18,009,696 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-19-003931 · ownership.xml · nonDerivative · entry 1 Hankey Don · CIK 0001561288 · Director · Chairman of the Board · 10% owner HANKEY CAPITAL, LLC · CIK 0001675964 · 10% owner Don Hankey Trust · CIK 0001747743 · affiliate of 10% owner/dir Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Hankey Capital, LLC Disclosed balance after: 24,210,421 F1 · shares: Consists of shares held by Hankey Capital LLC ("Hankey Capital") as collateral for the repayment of convertible notes (the "Notes") issued to Hankey Capital (the "Collateral Shares"). Hankey Capital may not transfer, sell or otherwise dispose of any of the Collateral Shares, except during the existence of Event of Default under the Notes in connection with the exercise of its rights and remedies as a secured lender. Hankey Capital is owned by Hankey Investment Company LP ("HIC") of which the Don Hankey Trust (the "Trust") owns a 66.09% interest. HIC is owned by Knight Services Inc. of which the Trust is the sole owner. Don Hankey is the sole trustee of the Trust. Mr. Hankey disclaims beneficial ownership in the shares held by Hankey Capital except to the extent of his pecuniary interest. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.